BPC-157 & TB-500 Blend 10mg is supplied strictly for laboratory research use only
It does not inhibit or induce CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, or CYP3A4, according to in vitro data cited in the FDA label
This emphasizes the challenge of interpreting pooled results across diverse study populations and highlights the need for patient-level data to understand treatment response in HFpEF better
We propose this is because Gdh2 is still present and has a high affinity for the enzymatic deamination of glutamate into -ketoglutarate
It is prescribed off label by peptide clinics for healthy adults seeking wellness benefits
There is no evidence that this move has impacted our survey findings and we will continue to monitor any suspected impacts